Cargando…
Allosteric Control of Ligand Binding Affinity Using Engineered Conformation-Specific Effector Proteins
We describe a phage display methodology to engineer synthetic antigen binders (sABs) that recognize either the apo- or the ligand-bound conformation of maltose binding protein (MBP). sABs that preferentially recognize the maltose-bound form of MBP act as positive allosteric effectors by significantl...
Autores principales: | Rizk, Shahir S., Paduch, Marcin, Heithaus, John H., Duguid, Erica M., Sandstrom, Andrew, Kossiakoff, Anthony A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077571/ https://www.ncbi.nlm.nih.gov/pubmed/21378967 http://dx.doi.org/10.1038/nsmb.2002 |
Ejemplares similares
-
Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling
por: Rizk, Shahir S, et al.
Publicado: (2015) -
Targeted rescue of cancer-associated IDH1 mutant activity using an engineered synthetic antibody
por: Rizk, Shahir S., et al.
Publicado: (2017) -
Discovery of High-Affinity Noncovalent Allosteric
KRAS Inhibitors That Disrupt Effector Binding
por: McCarthy, Michael J., et al.
Publicado: (2019) -
Antibody-protein binding and conformational changes: identifying allosteric signalling pathways to engineer a better effector response
por: Al Qaraghuli, Mohammed M., et al.
Publicado: (2020) -
Engineered Ultra-High Affinity Synthetic Antibodies for SARS-CoV-2 Neutralization and Detection
por: Slezak, Tomasz, et al.
Publicado: (2021)